Korea Hemophilia Society required to withdraw supply cut movement of 'Kogenate FS Injection' of Bayer

Korea Hemophilia Society which is a meeting of hemophilia patients and their parents, criticized health authorities and Bayer due to supply cut movement of 'Kogenate FS Injection'.

Prior to that, on Feb 12, Bayer announced their position that they will discontinue supply of Kogenate FS in some countries including Korea, because they began work combining worldwide supply facitilies. They asked ...